IL17RA and central nervous system cancer: In the current study, since we observed the majority (60% or more) of the IL-17R+ glioma cells were also positive for one or more of these GSC markers, it is quite plausible that the IL-17R+ glioma cells constitute a population of GSCs and IL-17 may regulate glioma progression via direct influence on GSCs.